Renata PLC

Renata Limited, formerly known as Pfizer Limited, is a prominent and rapidly expanding pharmaceutical and animal health product company in Bangladesh. The company commenced operations in 1972 as Pfizer (Bangladesh) Limited. In 1993, Pfizer transferred ownership of its Bangladesh operations to local shareholders, leading to the renaming of the company to Renata Limited. Renata Limited's primary focus areas include human pharmaceuticals and animal health products. In Bangladesh, it stands as the fourth-largest pharmaceutical company and holds the leading position in the market for animal health products. Additionally, Renata's products are exported to various countries, including Afghanistan, Belize, Cambodia, Ethiopia, Guyana, Honduras, Hong Kong, Kenya, Malaysia, Myanmar, Nepal, Philippines, Sri Lanka, Thailand, the United Kingdom, and Vietnam. The company is listed on the Dhaka Stock Exchange, boasting a market capitalization exceeding USD $1 billion. Renata Limited operates ten manufacturing facilities across three manufacturing sites, and its product distribution is facilitated by 19 depots spread throughout the country. The company's significant presence and diverse product portfolio contribute to its position as a key player in the pharmaceutical and animal health industries in Bangladesh and beyond.